{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:17:20Z","timestamp":1761005840812,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30800546"],"award-info":[{"award-number":["30800546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People&apos;s Republic of China","doi-asserted-by":"publisher","award":["200802841008"],"award-info":[{"award-number":["200802841008"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jrnjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1053\/j.jrn.2010.06.019","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T04:20:53Z","timestamp":1284697253000},"page":"309-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of Metabolic Risk Marker in Obesity-related Glomerulopathy"],"prefix":"10.1053","volume":"21","author":[{"given":"Hui-Mei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-De","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei-Shi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2010.06.019_bib1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2471\/BLT.07.048785","article-title":"Morbid obesity in a developing country: the Chilean experience","volume":"86","author":"Bambs","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1053\/j.jrn.2010.06.019_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1467-789X.2007.00431.x","article-title":"The challenge of obesity and related disease control in China","volume":"9","author":"Bekedam","year":"2008","journal-title":"Obes Rev"},{"key":"10.1053\/j.jrn.2010.06.019_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1467-789X.2007.00433.x","article-title":"Overview of obesity in Mainland China","volume":"9","author":"Chen","year":"2008","journal-title":"Obes Rev"},{"key":"10.1053\/j.jrn.2010.06.019_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2008.02.303","article-title":"Obesity-related glomerulopathy in China: a case series of 90 patients","volume":"52","author":"Chen","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2010.06.019_bib5","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","article-title":"Obesity-related glomerulopathy: an emerging epidemic","volume":"59","author":"Kambham","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.06.019_bib6","unstructured":"Shen WW, Chen HM, Chen H, et al: Obesity-related glomerulopathy: body mass index and proteinuria. Clin J Am Soc Nephrol (in press)"},{"key":"10.1053\/j.jrn.2010.06.019_bib7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2215\/CJN.04071206","article-title":"Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease","volume":"2","author":"Wahba","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2010.06.019_bib8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/dmrr.727","article-title":"Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique","volume":"23","author":"Bevier","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1053\/j.jrn.2010.06.019_bib9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.ijo.0801624","article-title":"A disparity between conventional lipid and insulin resistance markers at body mass index levels greater than 34 kg\/m(2)","volume":"25","author":"Dixon","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1053\/j.jrn.2010.06.019_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1053\/j.jrn.2010.06.019_bib11","doi-asserted-by":"crossref","first-page":"E501","DOI":"10.1152\/ajpendo.2000.278.3.E501","article-title":"Roles of insulin resistance and obesity in regulation of plasma insulin concentrations","volume":"278","author":"Jones","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1053\/j.jrn.2010.06.019_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-2007-985382","article-title":"Metabolic characteristics of glucose intolerance: the critical role of obesity","volume":"116","author":"Sainaghi","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1053\/j.jrn.2010.06.019_bib13","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.jrn.2010.06.019_bib14","first-page":"E6","article-title":"Amylin influences insulin-stimulated glucose metabolism by two independent mechanisms","volume":"274","author":"Castle","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jrn.2010.06.019_bib15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1681\/ASN.2007101128","article-title":"Lipid abnormalities and cardiovascular risk in renal disease","volume":"19","author":"Ritz","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2010.06.019_bib16","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/ajcn\/87.6.1585","article-title":"Intermuscular lipid: a marker of disordered fat partitioning or the consequence of obesity?","volume":"87","author":"Elbein","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.jrn.2010.06.019_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","article-title":"Use of metabolic markers to identify overweight individuals who are insulin resistant","volume":"139","author":"McLaughlin","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jrn.2010.06.019_bib18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/oby.2007.59","article-title":"Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects","volume":"16","author":"Gatti","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.jrn.2010.06.019_bib19","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1053\/j.ajkd.2006.07.025","article-title":"Podocyte lesions in patients with obesity-related glomerulopathy","volume":"48","author":"Chen","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2010.06.019_bib20","first-page":"83","article-title":"Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2014study on optimal cut-off points of body mass index and waist circumference in Chinese adults","volume":"15","author":"Zhou","year":"2002","journal-title":"Biomed Environ Sci"},{"key":"10.1053\/j.jrn.2010.06.019_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0272-6386(12)81023-7","article-title":"Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy","volume":"16","author":"Lemann","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2010.06.019_bib22","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1053\/j.jrn.2010.06.019_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00000441-200209000-00003","article-title":"Mechanisms of obesity-associated cardiovascular and renal disease","volume":"324","author":"Hall","year":"2002","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.jrn.2010.06.019_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-2007-992117","article-title":"The relationship between body fat distribution and renal damage in Chinese with obesity","volume":"116","author":"Chen","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1053\/j.jrn.2010.06.019_bib25","doi-asserted-by":"crossref","first-page":"c163","DOI":"10.1159\/000115329","article-title":"Glucose metabolism, insulin resistance, and renal pathology in non-diabetic chronic kidney disease","volume":"108","author":"Ikee","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.jrn.2010.06.019_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5414\/CNP69010","article-title":"Impact of age, body mass index, insulin resistance and proteinuria on the kidney function in obese patients with Type 2 diabetes and renal insufficiency","volume":"69","author":"Koch","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.jrn.2010.06.019_bib27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1507\/endocrj.K08E-094","article-title":"Homeostasis model assessment-insulin resistance (HOMA-IR), a key role for assessing the ovulation function in polycystic ovary syndrome (PCOS) patients with insulin resistance","volume":"55","author":"Ma","year":"2008","journal-title":"Endocr J"},{"key":"10.1053\/j.jrn.2010.06.019_bib28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.clinbiochem.2007.05.009","article-title":"Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons","volume":"40","author":"Vogeser","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1053\/j.jrn.2010.06.019_bib29","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"issue":"Suppl 2","key":"10.1053\/j.jrn.2010.06.019_bib30","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/(SICI)1096-9136(199706)14:2+<S9::AID-DIA397>3.0.CO;2-D","article-title":"Amylin: history and overview","volume":"14","author":"Ludvik","year":"1997","journal-title":"Diabet Med"},{"key":"10.1053\/j.jrn.2010.06.019_bib31","first-page":"131","article-title":"Increased levels of plasma amylin in advanced renal failure","volume":"37","author":"Watschinger","year":"1992","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.jrn.2010.06.019_bib32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-2007-978924","article-title":"Effects of rat amylin on renal function in the rat","volume":"30","author":"Vine","year":"1998","journal-title":"Horm Metab Res"},{"key":"10.1053\/j.jrn.2010.06.019_bib33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-5793(99)00894-7","article-title":"Induction of apoptosis by human amylin in RINm5F islet beta-cells is associated with enhanced expression of p53 and p21WAF1\/CIP1","volume":"455","author":"Zhang","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1053\/j.jrn.2010.06.019_bib34","first-page":"541","article-title":"Amylin induces apoptosis of cultured human mesangial cells","volume":"11","author":"Peng","year":"2002","journal-title":"J Nephrol Dialy Transplant"},{"key":"10.1053\/j.jrn.2010.06.019_bib35","first-page":"154","article-title":"Amylin increase permeability and endocytosis of human umbilical endothelial cell in vitro","volume":"13","author":"Peng","year":"2004","journal-title":"J Nephrol Dialy Transplant"},{"key":"10.1053\/j.jrn.2010.06.019_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5002305","article-title":"Amylin deposition in the kidney of patients with diabetic nephropathy","volume":"72","author":"Gong","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.06.019_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.ki.5002586","article-title":"Association between obesity and kidney disease: a systematic review and meta-analysis","volume":"73","author":"Wang","year":"2008","journal-title":"Kidney Int"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227610001706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227610001706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:32:47Z","timestamp":1760941967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227610001706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1051227610001706"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2010.06.019","relation":{},"ISSN":["1051-2276"],"issn-type":[{"type":"print","value":"1051-2276"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Metabolic Risk Marker in Obesity-related Glomerulopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Renal Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jrn.2010.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}